Cirrosis Hepática Alcohólica: análisis epidemiológico de la tasa de egreso hospitalario en Chile (2020-2023)

Annette María Palomino Núñez; Isaac Alexander Villegas Gañan; Carolina Andrea Donoso Díaz; Fabián Antonio Toro Marchant; Hugo Nicolas Argel Velasquez; Francisco Rodriguez Barrios

doi:10.5281/zenodo.19055946

Authors

Annette María Palomino Núñez Médico Cirujano, Centro de Salud Familiar Curicó Centro, Maule, Chile. Author https://orcid.org/0009-0003-2053-4800
Isaac Alexander Villegas Gañan Médico Cirujano, Universidad Central de Venezuela, Venezuela. Author https://orcid.org/0009-0007-0298-0910
Carolina Andrea Donoso Díaz Estudiante de Medicina, Universidad Bernardo O’Higgins, Santiago, Chile. Author https://orcid.org/0009-0004-7781-5117
Fabián Antonio Toro Marchant Estudiante de Medicina, Universidad Andrés Bello, Viña del Mar, Chile. Author https://orcid.org/0009-0008-4013-5977
Hugo Nicolas Argel Velasquez Interno de Medicina, Universidad de Concepción, Concepción, Chile. Author https://orcid.org/0009-0000-1808-4837
Francisco Rodriguez Barrios Médico Cirujano, Universidad Franz Tamayo, Santa Cruz de la Sierra, Bolivia. Author https://orcid.org/0009-0001-5346-7128

DOI:

https://doi.org/10.5281/zenodo.19055946

Keywords:

Chile, Hospitalization, Alcohol Liver Cirrhosis

Abstract

Introduction: Alcoholic liver cirrhosis (ALC) represents the final stage of alcohol-related liver disease (ALD), characterized by hepatic fibrosis, and constitutes a significant cause of morbidity, mortality, and hospitalization. In Chile, recent epidemiological information regarding its hospital-related patterns is limited, particularly following the COVID-19 pandemic. Objective: To describe the hospital discharge rate (HDR) for ALC in Chile during the period 2020–2023. Methodology: An observational, descriptive, and quantitative study was conducted using statistical data from the Department of Health Statistics and Information (DEIS) and the National Institute of Statistics (INE). The variables analyzed included sex, age group, and average length of hospital stay. Ethics committee approval was not required. Results: A total of 3,249 hospital discharges due to ALC were recorded during the study period, with an average HDR of 6.34 per 100,000 inhabitants. The highest HDR was observed in 2022, reaching 6.79 per 100,000 inhabitants. Males presented the highest HDR during the period, with 11.02 per 100,000 inhabitants. The age group with the highest HDR was 65–79 years, with a rate of 13.83 per 100,000 inhabitants. The average length of hospital stay was 11.21 days. Conclusion: ALC represents a significant hospital burden in Chile, with a predominance among men and older adults. These findings provide updated epidemiological information that may contribute to health planning and prevention strategies.

Downloads

Download data is not yet available.

References

1. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154–181. Disponible en: https://doi.org/10.1016/j.jhep.2018.03.018

2. Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388-398. Disponible en: https://doi.org/10.1038/s41575-023-00759-2

3. Shi C, Shi H, Chen C, Liu Y, Lv Y, Zhang H, Liang P. Trends of hospitalisation for patients with liver cirrhosis in Ningxia, China: a cross-sectional study. BMJ Open. 2023;22(13): e068655. Disponible en: http://doi.org/10.1136/bmjopen-2022-068655

4. Roblero J. Enfermedad hepática asociada al alcohol. En: González Donoso R, Cortés González P, Sáenz Fuenzalida R, Rollán Rodríguez A, Riquelme Pérez A. Diagnóstico y tratamiento de las enfermedades digestivas. Santiago de Chile: Sociedad Chilena de Gastroenterología; 2022. p 351-357.

5. Betancourt Masri L, Ávalos Meneses N, Olave Lira J, Gallegos Toro J, Sánchez Castro A. Defunciones por Cirrosis Hepática Alcohólica en Chile: tendencias y desigualdades territoriales. 2025. Rev Andes, 1(3),24-30. Disponible en: https://revista-andes.cl/ojs/index.php/inicio/article/view/40

6. Díaz D, Rocandio S, Cabezas C, Pastene F, Aldunate P. Cirrosis Hepática Alcohólica: actualización epidemiológica de la tasa de mortalidad entre los años 2017-2021 en Chile. Rev ANACEM. 2023;17:81 -85.

7. Jameson JL, Kasper DL, Fauci AS, Hauser SL, Longo DL, Loscalzo J, eds. Principios de medicina interna de Harrison. 20.ª ed. Nueva York: McGraw-Hill; 2018. p 2405

8. Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, Shah VH. ACG Clinical guideline: alcohol-associated liver disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54. Disponible en: http://doi.org/10.14309/ajg.0000000000002572

9. Juanola A, Pose E, Ginès P. Liver cirrhosis: ancient disease, new challenge. Med Clin (Barc). 2025 Mar 14;164(5):238-246. Disponible en: https://doi.org/10.1016/j.medcli.2024.11.002

10. Smith A, Baumgartner K, Bositis C. Cirrhosis: Diagnosis and management. Am Fam Physician. 2019. 15;100(12):759-770.

11. Testino G, Pellicano R. Alcohol consumption in the COVID-19 era. Minerva Gastroenterol Dietol. 2020;66(2):90-92. Disponible en: https://doi.org/10.23736/s1121-421x.20.02698-7

12. Da BL, Im GY, Schiano TD. Coronavirus disease 2019 Hangover: A rising tide of alcohol use disorder and alcohol-associated liver disease. Hepatology. 2020;72(3):1102-1108. Disponible en: http://doi.org/10.1002/hep.31307

13. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;14(395):912-920. Disponible en: https://doi.org/10.1016/S0140-6736(20)30460-8

14. Wei M, Ford J, Li Q, Jeong D, Kwong AJ, Nguyen MH, et al. Hospital cirrhosis volume and readmission in patients with cirrhosis in california. Dig Dis Sci. 2019;64(5):1392-1394. Disponible en: http://doi.org/10.1007/s10620-019-05558-x

15. Brahmania M, Wiskar K, Walley KR, Celi LA, Rush B. Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis. J Gastroenterol Hepatol. 2021;36(4):1088-1094. Disponible en: https://doi.org/10.1111/jgh.15153

16. Angulo Pico, G., Mercado Mejía M. Efectos económicos y comerciales de la covid-19: una revisión desde la economía internacional. Revi Relac Int Estrateg Segur. 2023;18(1):129–144. Disponible en: http://www.scielo.org.co/scielo.php?pid=S1909-30632023000100129&script=sci_arttext

17. GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018; 392:1015-1035. Disponible en: http://doi.org/10.1016/S0140-6736(18)31310-2

18. Mellinger JL. Epidemiology of alcohol use and alcoholic liver disease. Clin Liver Dis (Hoboken). 2019;13(5):136-139. Disponible en: http://doi.org/10.1002/cld.806

19. Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas y Alcohol (SENDA); Ministerio de Salud (MINSAL). El consumo de alcohol en Chile: situación epidemiológica [Internet]. Santiago de Chile: SENDA–MINSAL; 2016 [citado 2025 Dic 27]. Disponible en: https://www.senda.gob.cl/wp-content/uploads/media/estudios/otrosSENDA/2016_Consumo_Alcohol_Chile.pdf

20. Marcellin P, Kutala BK. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 2018;38:2-6. Disponible en: https://doi.org/10.1111/liv.13682

21. Tamburello A, Marando M, Bellentani S. Alcohol consumption in late adolescence is associated with an increased risk of severe liver disease later in life. Ann Hepatol. 2018;17(3):343-344. Disponible en: https://doi.org/10.5604/01.3001.0011.7379

22. Lee HY, Hwang J, Ball JG, Lee J, Yu Y, Albright DL. Mental health literacy affects attitudes toward mental health: Is there a gender difference? Am J Health Behav. 2020;44(3):282-291. Disponible en: https://doi.org/10.5993/AJHB.44.3.1

23. Ministerio de Desarrollo Social y Familia [Internet]. Ministerio de Desarrollo Social y Familia. [citado el 24 de febrero de 2025]. Disponible en: https://www.desarrollosocialyfamilia.gob.cl/noticias/gobierno-entrega-resultados-del-primer-estudio-sobre-consumo-de-drogas-y-alcohol-en-personas-mayores

24. Wang X, Luo JN, Wu XY, Zhang QX, Wu B. Study of liver cirrhosis over twenty consecutive years in adults in Southern China. World J Hepatol. 2023; 15(12): 1294-1306. Disponible en: https://doi.org/10.4254/wjh.v15.i12.1294

25. Hanai T, Nishimura K, Unome S, Miwa T, Nakahata Y, Imai K, et al. Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis. J Gastroenterol. 2024;59(10):932-940. Disponible en: https://doi.org/10.1007/s00535-024-02137-4

26. Aslam A, Kwo PY. Epidemiology and disease burden of alcohol associated liver disease. J Clin Exp Hepatol. 2023;13(1):88-102. Disponible en: https://doi.org/10.1016/j.jceh.2022.09.001

27. Vaz J, Eriksson B, Strömberg U, Buchebner D, Midlöv P. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. BMC Gastroenterol. 2020 Apr 3;20(1):84. Disponible en: https://doi.org/10.1186/s12876-020-01239-6

28. Kim Y, Reddy S, Mouchli M, Summey R, Walsh C, Mir A, et al. Gender-specific risk factors contributing to mortality in patients hospitalized with alcoholic cirrhosis. Cureus. 2021 Jul;13(7):e16271. Disponible en: http://doi.org/10.7759/cureus.16271

29. Trifan A, Minea H, Rotaru A, Stanciu C, Stafie R, Stratina E, et al. Predictive factors for the prognosis of alcoholic liver cirrhosis. Medicina (Kaunas). 2022. 16:58(12). Disponible en: https://doi.org/10.3390/medicina58121859

30. Gu W, Hortlik H, Erasmus HP, Schaaf L, Zeleke Y, Uschner FE, et al. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur. 2021 4; 12:100240. Disponible en: https://doi.org/10.1016/j.lanepe.2021.100240